UpToDate’s Post

Today we observe #WorldHepatitisDay to raise awareness. With a person dying every 30 seconds from hepatitis-related illness, it’s #TimeforAction on better prevention, diagnosis, and treatment to save lives and improve health outcomes. We support the World Health Organization elimination goal by 2030 – together we can make hepatitis elimination a reality. #UpToDateSupportsHealth

"GenAI will help healthcare reach its destination of efficiency and superior outcomes, but we can’t lose sight of the need for human touch, quality interactions and data to navigate us forward," explains President and CEO, Greg Samios via MedCity News. https://ow.ly/NY0B50SLnYq

#Payers can start preparing for 2027 CMS #healthequity changes by implementing strategies for better outcomes, streamlined operations, and higher #Starsratings now. Read our Expert Insight to learn more and download the eBook, “Preparing for 2027: Driving health equity with inclusive member education.” https://ow.ly/bIZt50SIFkb #caremanagement

Working together, #payers and providers can combat #cardiovasclulardisease and change the trajectory of a disease that claims almost 18 million lives a year. Read our Expert Insight to learn how. https://ow.ly/j9Ww50St9jp #CVD #PayerProviderCollaboration #CardiovascularHealth

The FDA has approved a new indication for Phathom Pharmaceuticals’ Voquezna (vonoprazan) oral tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease in adults. For all the latest drug news, check out our drug referential resource: https://ow.ly/KJNo50SJqNh. #DrugNews #Pharmacy #Medication #Heartburn

The answer to yesterday’s #ClinicalChallenge questions is: True. In a recent study of 419 patients with subarachnoid hemorrhage, 12 percent developed epilepsy over a median follow up of four years. Risk factors included premorbid functional impairment, cerebral ischemia related to the hemorrhage, surgical treatment of the aneurysm, and early seizures. View the related What's New topic in #UpToDate: https://ow.ly/SxMM50Snnh6 #neurology #meded

GLP-1 medications have become wildly popular to treat #obesity. Our Expert Insight reveals how prescribers, pharmacists, and care managers can manage patient expectations, educate on safe usage, and leverage evidence-based resources to stay current with shortages and best practices. https://ow.ly/37ez50SHfiQ #GLP1 #WeightManagement

🧠 #ClinicalChallenge #neurology #meded

Primary care providers are now delivering 60% of #mentalhealth care, despite not being formally trained specialists. Our Expert Insight reveals how organizational support and evidence-based solutions can help PCPs shoulder some of this burden. Read now: https://ow.ly/PK6K50Sw17X